Rock Springs Capital Management LP Seagen Inc. Transaction History

Rock Springs Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $15 Million - $17.8 Million	128,200 Added 47.13%	400,200 $51.4 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $163,215 - $268,995	1,500 Added 0.55%	272,000 $48.1 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.73 Million - $2.29 Million	14,500 Added 5.66%	270,500 $39 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $855,420 - $1.15 Million	6,000 Added 2.4%	256,000 $39.6 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $41.2 Million - $53 Million	250,000 New	250,000 $43.8 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.